Biocon Ltd.
| BSE: 532523 | Sector: Health care |
| NSE: BIOCON | ISIN Code: INE376G01013 |
| BSE 00:00 | 24 Apr 2020 | Biocon Ltd |
| NSE 05:30 | 01 Jan 1970 | Biocon Ltd |
Notice: Undefined property: stdClass::$market_capital_for_nse in /usr2/unibs/application/modules/live-market/views/scripts/company/bs-new-bse-nse-block.php on line 17
| OPEN | 342.05 |
| PREVIOUS CLOSE | 347.55 |
| VOLUME | 341566 |
| 52-Week high | 367.80 |
| 52-Week low | 211.30 |
| P/E | 141.21 |
| Mkt Cap.(Rs cr) | 42,870 |
| Buy Price | 356.30 |
| Buy Qty | 100.00 |
| Sell Price | 357.25 |
| Sell Qty | 51.00 |
Biocon Ltd. (BIOCON) - Announcements
-
Biocon Ltd Board Meeting Intimation for Intimation For The Board Meeting And Trading Window Closure
22/04/2020 | bse |
Downlaod PDF -
Biocon Ltd Statement Of Investor Complaints For The Quarter Ended March 2020
21/04/2020 | bse
-
Biocon Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
20/04/2020 | bse |
Downlaod PDF -
Biocon Ltd Shareholding for the Period Ended March 31 2020
16/04/2020 | bse
-
Biocon Ltd Company Statement - Biocon Biologics Receives EIR From U.S. FDA For Two Manufacturing Facilities Ins
16/04/2020 | bse |
Downlaod PDF -
Biocon Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
14/04/2020 | bse |
Downlaod PDF -
Biocon Ltd Compliance Certificate Under Regulation 7 (3) Of SEBI (Listing Obligations And Disclosure Requiremen
13/04/2020 | bse |
Downlaod PDF -
Biocon Ltd Compliance Certificate Under Regulation 40 (9) Of SEBI Listing Regulations For The Half Year Ended<B
13/04/2020 | bse |
Downlaod PDF -
Biocon Ltd Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
13/04/2020 | bse |
Downlaod PDF -
Biocon Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
08/04/2020 | bse |
Downlaod PDF -
Biocon Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
08/04/2020 | bse |
Downlaod PDF -
Biocon Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
01/04/2020 | bse |
Downlaod PDF -
Biocon Ltd Company Statement - BioconS Insulin Manufacturing Facility In Malaysia Receives EIR From U.S. FDA Wi
01/04/2020 | bse |
Downlaod PDF -
Biocon Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
27/03/2020 | bse |
Downlaod PDF -
Biocon Ltd Company Statement - Biocons Receives EIR For Small Molecules API Manufacturing Facility For Post -Ap
20/03/2020 | bse |
Downlaod PDF -
Biocon Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
12/03/2020 | bse |
Downlaod PDF -
Biocon Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
11/03/2020 | bse |
Downlaod PDF -
Biocon Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
09/03/2020 | bse |
Downlaod PDF -
Biocon Ltd Announcement under Regulation 30 (LODR)-Press Release / Media Release
09/03/2020 | bse |
Downlaod PDF -
Biocon Ltd Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
06/03/2020 | bse |
Downlaod PDF
Quick Links for Biocon:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
Notice: Undefined variable: mediaAbsUrl in /usr2/unibs/application/modules/live-market/controllers/CompanyController.php on line 5069